{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:46Z","timestamp":1793407306661,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03449-w","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T10:02:16Z","timestamp":1689674536000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-765X","authenticated-orcid":false,"given":"Huy Gia","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"issue":"8","key":"3449_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"D.N. Louis, A. Perry, P. Wesseling et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23(8), 1231\u20131251 (2021)","journal-title":"Neuro Oncol."},{"issue":"1","key":"3449_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"S.L. Asa, O. Mete, A. Perry, R.Y. Osamura, Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr. Pathol. 33(1), 6\u201326 (2022)","journal-title":"Endocr. Pathol."},{"issue":"3","key":"3449_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"O. Mete, M.B. Lopes, Overview of the 2017 WHO Classification of Pituitary Tumors. Endocr. Pathol. 28(3), 228\u2013243 (2017)","journal-title":"Endocr. Pathol."},{"issue":"8","key":"3449_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","volume":"154","author":"H Alahmadi","year":"2012","unstructured":"H. Alahmadi, D. Lee, J.R. Wilson et al. Clinical features of silent corticotroph adenomas. Acta Neurochirurgica 154(8), 1493\u20131498 (2012)","journal-title":"Acta Neurochirurgica"},{"issue":"1","key":"3449_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","volume":"58","author":"KJ Bradley","year":"2003","unstructured":"K.J. Bradley, J.A.H. Wass, H.E. Turner, Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin. Endocrinol. 58(1), 59\u201364 (2003)","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"3449_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","volume":"72","author":"HY Cho","year":"2010","unstructured":"H.Y. Cho, S.W. Cho, S.W. Kim, C.S. Shin, K.S. Park, S.Y. Kim, Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin. Endocrinol. 72(5), 648\u2013653 (2010)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"3449_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11060-017-2520-y","volume":"135","author":"O Cohen-Inbar","year":"2017","unstructured":"O. Cohen-Inbar, Z.Y. Xu, C.C. Lee et al. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study. J. Neuro-Oncol. 135(1), 67\u201374 (2017)","journal-title":"J. Neuro-Oncol."},{"issue":"6","key":"3449_CR8","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.JNS203236","volume":"135","author":"BA Strickland","year":"2021","unstructured":"B.A. Strickland, S. Shahrestani, R.G. Briggs et al. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J. Neurosurg. 135(6), 1706\u20131713 (2021)","journal-title":"J. Neurosurg."},{"issue":"4","key":"3449_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"M.B.S. Lopes, The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 134(4), 521\u2013535 (2017)","journal-title":"Acta Neuropathol."},{"issue":"7","key":"3449_CR10","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"D. Moher, A. Liberati, J. Tetzlaff, D. Altman; PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7), e1000097 (2009)","journal-title":"PLoS Med"},{"key":"3449_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"J.F. Tierney, L.A. Stewart, D. Ghersi, S. Burdett, M.R. Sydes, Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8, 16 (2007)","journal-title":"Trials"},{"issue":"11","key":"3449_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis. Stat. Med. 21(11), 1539\u20131558 (2002)","journal-title":"Stat. Med."},{"issue":"4","key":"3449_CR13","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.17826\/cumj.783225","volume":"45","author":"G Akkus","year":"2020","unstructured":"G. Akkus, B. Karagun, N.E. Cetinalp et al. Clinical, hormonal, radiological and morphological comparison of patients with clinically evident Cushing\u2019s disease and patients with silent corticotroph cell adenoma. Cukurova Med. J. 45(4), 1720\u20131732 (2020)","journal-title":"Cukurova Med. J."},{"key":"3449_CR14","doi-asserted-by":"crossref","unstructured":"T. Amano, T. Masumoto, D. Watanabe, et al. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI. Jpn J Radiol. 2023.","DOI":"10.1007\/s11604-023-01420-3"},{"key":"3449_CR15","doi-asserted-by":"publisher","first-page":"E241","DOI":"10.1016\/j.wneu.2018.08.043","volume":"120","author":"RL Batista","year":"2018","unstructured":"R.L. Batista, E.B. Trarbach, M.D. Marques et al. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile. World Neurosurg. 120, E241\u2013E246 (2018)","journal-title":"World Neurosurg."},{"issue":"6","key":"3449_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1530\/EJE-19-0194","volume":"181","author":"M Bujko","year":"2019","unstructured":"M. Bujko, P. Kober, J. Boresowicz et al. USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status. Eur. J. Endocrinol. 181(6), 615\u2013627 (2019)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"3449_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EC-20-0035","volume":"9","author":"S Castellnou","year":"2020","unstructured":"S. Castellnou, A. Vasiljevic, V. Lapras et al. SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors. Endocr. Connect. 9(3), 243\u2013253 (2020)","journal-title":"Endocr. Connect."},{"issue":"2","key":"3449_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","volume":"1","author":"O Cooper","year":"2010","unstructured":"O. Cooper, A. Ben-Shlomo, V. Bonert, S. Bannykh, J. Mirocha, S. Melmed, Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes. Horm. Cancer 1(2), 80\u201392 (2010)","journal-title":"Horm. Cancer"},{"key":"3449_CR19","doi-asserted-by":"crossref","unstructured":"A. Garcia-Martinez, A.C. Fuentes-Fayos, C. Fajardo, et al. Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors. J. Clin. Med. 9(6); (2020)","DOI":"10.3390\/jcm9061838"},{"issue":"11","key":"3449_CR20","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00701-021-04911-2","volume":"163","author":"A Goyal-Honavar","year":"2021","unstructured":"A. Goyal-Honavar, S. Sarkar, H.S. Asha et al. A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors. Acta Neurochirurgica 163(11), 3143\u20133154 (2021)","journal-title":"Acta Neurochirurgica"},{"issue":"4","key":"3449_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jnci.2011.11.003","volume":"23","author":"IH Hewedi","year":"2011","unstructured":"I.H. Hewedi, W.M. Osman, M.M. El Mahdy, Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27\/Kip1 labeling indices. J. Egypt Natl Canc Inst. 23(4), 171\u2013179 (2011)","journal-title":"J. Egypt Natl Canc Inst."},{"key":"3449_CR22","doi-asserted-by":"publisher","first-page":"E274","DOI":"10.1016\/j.wneu.2022.01.119","volume":"161","author":"L Huang","year":"2022","unstructured":"L. Huang, G. Fatterpekar, S. Charles, D. Golub, D. Zagzag, N. Agrawal, Clinical Course and Unique Features of Silent Corticotroph Adenomas. World Neurosurg. 161, E274\u2013E281 (2022)","journal-title":"World Neurosurg."},{"issue":"2","key":"3449_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","volume":"71","author":"AG Ioachimescu","year":"2012","unstructured":"A.G. Ioachimescu, L. Eiland, V.S. Chhabra et al. Silent Corticotroph Adenomas: Emory University Cohort and Comparison With ACTH-Negative Nonfunctioning Pituitary Adenomas. Neurosurgery 71(2), 296\u2013303 (2012)","journal-title":"Neurosurgery"},{"issue":"1","key":"3449_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","volume":"73","author":"A Jahangiri","year":"2013","unstructured":"A. Jahangiri, J.R. Wagner, M. Pekmezci et al. A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73(1), 8\u201317 (2013).","journal-title":"Neurosurgery"},{"issue":"4","key":"3449_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11102-021-01133-8","volume":"24","author":"SZ Jiang","year":"2021","unstructured":"S.Z. Jiang, J.Y. Zhu, M. Feng et al. Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24(4), 564\u2013573 (2021)","journal-title":"Pituitary"},{"key":"3449_CR26","doi-asserted-by":"publisher","first-page":"E464","DOI":"10.1016\/j.wneu.2018.04.070","volume":"115","author":"D Kim","year":"2018","unstructured":"D. Kim, C.R. Ku, S.H. Park et al. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas. World Neurosurg. 115, E464\u2013E471 (2018)","journal-title":"World Neurosurg."},{"issue":"3","key":"3449_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12020-017-1447-6","volume":"58","author":"F Langlois","year":"2017","unstructured":"F. Langlois, D.S.T. Lim, E. Varlamov et al. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine 58(3), 528\u2013534 (2017)","journal-title":"Endocrine"},{"issue":"4","key":"3449_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"H. Nishioka, N. Inoshita, O. Mete et al. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas. Endocr. Pathol. 26(4), 349\u2013355 (2015)","journal-title":"Endocr. Pathol."},{"issue":"3","key":"3449_CR29","first-page":"347","volume":"29","author":"M Pawlikowski","year":"2008","unstructured":"M. Pawlikowski, J. Kunert-Radek, M. Radek, \"Silent\"corticotropinoma. Neuro Endocrinol. Lett. 29(3), 347\u2013350 (2008)","journal-title":"Neuro Endocrinol. Lett."},{"issue":"7","key":"3449_CR30","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"L.G. Perez-Rivas, M. Theodoropoulou, F. Ferrau et al. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing\u2019s Disease. J. Clin. Endocrinol. Metab. 100(7), E997\u2013E1004 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3449_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1530\/EJE-11-0566","volume":"165","author":"R Reddy","year":"2011","unstructured":"R. Reddy, S. Cudlip, J.V. Byrne, N. Karavitaki, J.A. Wass, Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? Eur. J. Endocrinol. 165(5), 739\u2013744 (2011)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"3449_CR32","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2014.10.FOCUS14705","volume":"38","author":"TR Smith","year":"2015","unstructured":"T.R. Smith, M.M. Hulou, K.T. Huang et al. Complications after transsphenoidal surgery for patients with Cushing\u2019s disease and silent corticotroph adenomas. Neurosurg. Focus. 38(2), E12 (2015)","journal-title":"Neurosurg. Focus."},{"issue":"5","key":"3449_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1507\/endocrj.K07-059","volume":"54","author":"T Tateno","year":"2007","unstructured":"T. Tateno, H. Izumiyama, M. Doi, T. Akashi, K. Ohno, Y. Hirata, Defective expression of prohormone convertase 1\/3 in silent corticotroph adenoma. Endocr. J. 54(5), 777\u2013782 (2007)","journal-title":"Endocr. J."},{"issue":"3","key":"3449_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/cen.13365","volume":"87","author":"AK Watts","year":"2017","unstructured":"A.K. Watts, A. Easwaran, P. McNeill, Y.Y. Wang, W.J. Inder, C. Caputo, Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: Results from a single Australian centre. Clin. Endocrinol. (Oxf.) 87(3), 264\u2013271 (2017)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"3449_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ijrobp.2014.07.013","volume":"90","author":"ZY Xu","year":"2014","unstructured":"Z.Y. Xu, S. Ellis, C.C. Lee et al. Silent Corticotroph Adenomas After Stereotactic Radiosurgery: A Case-Control Study. Int. J. Radiat. Oncol. Biol. Phys. 90(4), 903\u2013910 (2014)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"3449_CR36","doi-asserted-by":"publisher","first-page":"608691","DOI":"10.3389\/fendo.2020.608691","volume":"11","author":"KY Zhang","year":"2021","unstructured":"K.Y. Zhang, X.F. Shou, H. Chen et al. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases. Front. Endocrinol. (Lausanne) 11, 608691 (2021)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"3449_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","volume":"18","author":"O Cooper","year":"2015","unstructured":"O. Cooper, Silent corticotroph adenomas. Pituitary 18(2), 225\u2013231 (2015)","journal-title":"Pituitary"},{"issue":"4","key":"3449_CR38","first-page":"1039","volume":"104","author":"A Fountas","year":"2018","unstructured":"A. Fountas, A. Lavrentaki, A. Subramanian, K.A. Toulis, K. Nirantharakumar, N. Karavitaki, Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 104(4), 1039\u20131048 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3449_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1530\/EJE-20-1273","volume":"184","author":"NF Lenders","year":"2021","unstructured":"N.F. Lenders, A.C. Wilkinson, S.J. Wong et al. Transcription factor immunohistochemistry in the diagnosis of pituitary tumours. Eur. J. Endocrinol. 184(6), 891\u2013901 (2021)","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03449-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:13:00Z","timestamp":1698729180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03449-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03449-w","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}